NCT01501786View on ClinicalTrials.gov

Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Congenital Heart DiseaseSedated for Cardiac Catheterization
Interventions
DRUG

control

propofol 8mg/kg/h saline 0.24 ml/kg/h

DRUG

Ket10

propofol 6.4 mg/kg/h ketamine 10 microg/kg/min

DRUG

Ket20

propofol 4.8 mg/kg/h ketamine 20 microg/kg/min

Trial Locations (1)

311-4145

Ibaraki Children's Hospital, Mito

All Listed Sponsors
lead

Ibaraki Children's Hospital

OTHER

NCT01501786 - Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions | Biotech Hunter | Biotech Hunter